Imatinib Mesylate inhibits c-kit, PDGFR and c-ABL by perfectly binding to adenosine triphosphate (ATP)-binding sites of the c-kit protooncogene product, platelet-derived growth factor receptor (PDGFR), and abelson kinase (c-ABL). More information please visit the website: http://www.creative-enzymes.com/product/Imatinib-Mesylate_2228.html
Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products.Featured Products are API Peptides,Cosmetic Peptides and Catalog Peptides.We provide high quality products worldwide.
View more >>